The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...

T here's no part of the morning routine as sacred to so many of us as that first sip of freshly brewed coffee. In fact, most ...

Alembic Pharmaceuticals Ltd received final approval on Tuesday from the United States Food and Drug Administration (USFDA) ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11%, a study shows.

New research links constipation with increased heart risks, especially in people with high blood pressure. Experts interpret ...

Four new research papers highlight ways that health disparities appear commonly in cardiac care. Here is what they found, according to a Nov. 11 report from Stat: ...

Beta blockers are go-to meds for many people who've survived a heart attack, but might not be needed for patients whose ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US$ 145.3 million for twelve months ending September 2024 according to IQVIA.

According to Leissner's team, that's especially true for folks who have survived a heart attack but whose cardiac pumping ...

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ivabradine Tablets, 5 mg ...